Design Therapeutics, Inc. Balance Sheet
DSGN|3 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
Design Therapeutics, Inc. had $226M in total assets and $242M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2021 |
|---|---|---|---|
| Cash & Equivalents | $16.9M | $22.6M | $298.6M |
| Current Assets | $223.8M | $248.0M | $385.4M |
| PP&E (Net) | $981.0K | $1.4M | $1.5M |
| Total Assets | $226.2M | $252.1M | $390.6M |
| Current Liabilities | $13.1M | $8.5M | $5.3M |
| Shareholders' Equity | $242.1M | $277.7M | -$11.3M |